Biotech
The FDA has approved the CSF-1R inhibitor Pimicotinib (ABSK021) of Abbisko Therapeutics to enter the Pivotal Global Multi-center Phase III Clinical Trial
2023-03-16 10:00
2855
This is the first-ever global phase III trial for TGCT approved by NMPA and FDA. Pimicotinib(ABSK021)was granted BTD by FDA and CDE, discovered and developed byChina biotech。 SHANGHAI, March 16, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (HKEX Stock Code: 2256. HK, referred to as "Abbis...
Bridge Biotherapeutics to Present Updated Preclinical Data of BBT-207 at the AACR 2023 Annual Meeting
2023-03-15 21:00
1784
* The abstract of BBT-207 preclinical studies is now available on the AACR
website
HanAll Biopharma Opens Applications for the 2023 Pharmaceutical Industry Fellowship Program
2023-03-15 19:00
1696
* Applications for physicians trained in Indonesia now open until April 15, 2023 12:00 AM * The Pharmaceutical Industry Fellowship Program provides physicians with the opportunity to experience the various steps of the drug development process ROCKVILLE, Md. and SEOUL, South Korea, March 15, ...
Ascentage Pharma to Present Latest Results from Three Preclinical Studies at 2023 American Association for Cancer Research Annual Meeting
2023-03-15 07:59
2765
SUZHOU, China and ROCKVILLE, Md., March 14, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the latest results from three preclinical s...
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022
2023-03-14 18:30
1609
SUZHOU, China, March 14, 2023 /PRNewswire/ -- magAssist Inc.
BEYOND Expo Back in Macao for 2023 to See "Technology Redefined" in one of Asia's Biggest Tech Events
2023-03-14 09:00
2908
MACAO, March 14, 2023 /PRNewswire/ -- Now on its third edition, BEYOND International Technology Innovation Expo (BEYOND Expo) returns to its real-world conference format inMacao from May 10 to 12, 2023. The live-streamed and in-person conference format will provide exhibitors and attendees with m...
Patient Enrollment Completed for the Phase 3 Trial of Boan Biotech's Aflibercept Intravitreous Injection in China
2023-03-13 20:36
2235
YANTAI, China, March 13, 2023 /PRNewswire/ -- Luye Pharma Group today announced that patient enrollment has been completed for the Phase 3 clinical study (comparative clinical study of efficacy and safety) of BA9101 (Aflibercept Intravitreous Injection) inChina. This is an investigational ophthal...
Porton Advanced and Bennu Biotherapeutics Announced a Strategic Partnership to Accelerate Cell Therapy Development for Solid Tumors
2023-03-13 20:00
1449
SUZHOU, China, March 13, 2023 /PRNewswire/ -- On March 7th, 2023, Suzhou Porton Advanced Solutions Ltd. (Porton Advanced) and Bennu Biotherapeutics (Bennubio) announced a strategic partnership to advance cell and gene therapy R&D pipelines. The partnership aims to accelerate the development of T-...
Success for Surglasses Technology! First AR Surgery Completed in the United States
2023-03-10 16:26
1618
TAICHUNG, Taiwan, March 10, 2023 /PRNewswire/ -- Surglasses/Caduceus S from Taiwan Main Orthopaedic Biotechnology Co., Ltd. Achieves Landmark Success with Caduceus S AR Spine Navigation System for First Augmented Reality Surgery in the US using 2D C-Arm Imaging. Surglasses has achieved a signifi...
Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing
2023-03-10 09:00
1791
BOSTON, March 9, 2023 /PRNewswire/ -- Allorion Therapeutics ("Allorion"), a biotech company focusing on next-generation precision medicine for oncology and autoimmune diseases, announces the completion of a$50 million Series B financing round, co-led by INCE Capital and Qiming Venture Partners, w...
Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics
2023-03-09 20:01
2176
ZUG, Switzerland, March 9, 2023 /PRNewswire/ -- Alnylam Pharmaceuticals, Inc.
GenFleet Therapeutics to Present Phase I Data for GFH312 at 2023 American Society for Clinical Pharmacology & Therapeutics Meeting
2023-03-09 19:00
1489
SHANGHAI, March 9, 2023 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the results from phase I study of GFH312 (RIPK1 inhibitor) monotherapy will be presented as a poster at the 2023 ASC...
GRAND LAUNCHING OF DNATEST.ID, A COMPREHENSIVE DNA TEST IN INDONESIA
2023-03-09 10:00
2425
JAKARTA, Indonesia, March 9, 2023 /PRNewswire/ -- PT Henindo Technologies Citra Mulia (HENINDO) together with PT Regene Artifisial Inteligen (REGENE) announce the launching of a comprehensive DNA TEST under the brand name of DNAtest.id. The event was attended byProf. Dr. Amien Soebandrio, PhD, Sp...
JW Therapeutics Announces Initiation of Clinical Study of Carteyva® in First-line Treatment in Patients with High-Risk Large B-Cell Lymphoma
2023-03-08 17:30
2652
SHANGHAI, March 8, 2023 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the initiation of clinical study of Carteyva® (relmacabtagene autoleucel inje...
ONEDAY BIOTECH to unveil 'One Drilling System' at IDS 2023
2023-03-08 07:00
2937
* One Drilling System Completing the Implant Procedure with Just One Drilling Exclusively * Company Specializing in Implants Pursuing 'One-Day-Completion Implant' SEOUL, South Korea, March 8, 2023 /PRNewswire/ -- ONEDAY BIOTECH (CEO Kim Jin -hwan), a dental product manufacturer specializing in...
MSCI ESG Updated I-Mab to "A" Rating
2023-03-07 21:02
1617
GAITHERSBURG, MD. and SHANGHAI, March 7, 2023 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that I-Mab has been granted "A" rating by MSCI (Morgan ...
AnPac Bio Announces Receipt of the First Payment from a Malaysia Customer On a Signed US$1.5 Million Cancer Detection Equipment Purchase Contract
2023-03-07 20:30
1420
NEW YORK, March 7, 2023 /PRNewswire/ – AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio" or the "Company" (Nasdaq: ANPC), a company with operations inthe United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commer...
GenScript ProBio Congratulates Eutilex's IND Clearance from MFDS
2023-03-07 10:00
2026
NANJING, China, March 7, 2023 /PRNewswire/ -- Recently, Eutilex, a partner of GenScript ProBio, announced MFDS(Ministry of Food and Drug Safety) clearance of its hepatocellular carcinoma clinical trial application for innovative CAR-T program (EU307). GenScript ProBio extends congratulations o...
AnPac Bio-Medical Science Announces US$5 Million Private Placement
2023-03-06 21:30
3215
NEW YORK, March 6, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) ("AnPac Bio," the "Company" or "we"), a company with operations inthe United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business ...
Medidata Drives Diversity in Clinical Trials, Passing 30,000 Studies and 9 Million Participants
2023-03-03 09:00
2589
Unprecedented industry milestones achieved with continuous innovation
supporting the digital transformation of life sciences
SINGAPORE, March 3, 2023 /PRNewswire/ -- Known for its ground-breaking
technological innovations in clinical trials,Medidata
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 323 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07Most Read
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
9824
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
7343
Traveloka strengthens sustainability pledge as world's first Platinum Sponsor of GSTC
2024-05-13 16:42
7008